Results 271 to 280 of about 33,209,906 (421)
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 trial
Molecular Oncology, EarlyView.Using mass cytometry, we analyzed serial blood samples from patients with relapsed epithelial ovarian cancer (EOC) treated with oleclumab–durvalumab combination immunotherapy in the NSGO‐OV‐UMB1/ENGOT‐OV30 trial. Our analysis identified potential predictive, monitoring, and response biomarkers detectable through liquid biopsy. These findings facilitate Luka Tandaric, Annika Auranen, Katrin Kleinmanns, René DePont Christensen, Liv Cecilie Vestrheim Thomsen, Cara Ellen Wogsland, Emmet McCormack, Johanna Mäenpää, Kristine Madsen, Karen Stampe Petersson, Mansoor Raza Mirza, Line Bjørge +11 morewiley +1 more sourceResponse to neoadjuvant chemotherapy in early breast cancers is associated with epithelial–mesenchymal transition and tumor‐infiltrating lymphocytes
Molecular Oncology, EarlyView.Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.Françoise Derouane, Jérôme Ambroise, Cédric van Marcke, Mieke Van Bockstal, Martine Berlière, Christine Galant, Hélène Dano, Médina Lougué, Elena Benidovskaya, Guy Jerusalem, Vincent Bours, Claire Josse, Jérôme Thiry, Aurélie Daumerie, Caroline Bouzin, Cyril Corbet, François P. Duhoux +16 morewiley +1 more sourceThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Science, 2015 K. Ardlie, David S. DeLuca, A. Segrè, Timothy J. Sullivan, Taylor Young, Ellen T. Gelfand, Casandra A. Trowbridge, Julian B. Maller, T. Tukiainen, M. Lek, Lucas D. Ward, Pouya Kheradpour, Benjamin Iriarte, Yan Meng, Cameron D. Palmer, T. Esko, W. Winckler, J. Hirschhorn, M. Kellis, D. MacArthur, Gad Getz, A. A. Shabalin, Gen Li, Yi-Hui Zhou, A. Nobel, I. Rusyn, Fred A. Wright, Tuuli Lappalainen, Pedro G. Ferreira, H. Ongen, Manuel A. Rivas, Alexis Battle, Sara Mostafavi, Jean Monlong, M. Sammeth, Marta Melé, F. Reverter, Jakob M. Goldmann, Daphne Koller, R. Guigó, Mark I. McCarthy, E. Dermitzakis, Eric R. Gamazon, Hae K. Im, A. Konkashbaev, D. Nicolae, Nancy J. Cox, T. Flutre, Xiaoquan Wen, Matthew Stephens, Jonathan K. Pritchard, Zhidong Tu, Bin Zhang, Tao Huang, Quan Long, Luan Lin, Jialiang Yang, Jun Zhu, Jun S. Liu, A. Brown, Bernadette Mestichelli, D. Tidwell, E. Lo, Mike Salvatore, Saboor Shad, Jeffrey A. Thomas, John T. Lonsdale, M. T. Moser, Bryan M. Gillard, E. Karasik, Kimberly Ramsey, Christopher Choi, Barbara A. Foster, John Syron, Johnelle Fleming, Harold Magazine, Rick Hasz, Gary Walters, J. Bridge, Mark Miklos, Susan Sullivan, Laura K. Barker, H. Traino, M. Mosavel, L. Siminoff, Dana R. Valley, D. Rohrer, Scott D. Jewell, P. Branton, L. Sobin, M. Barcus, L. Qi, J. McLean, P. Hariharan, K. S. Um, Shenpei Wu, David E. Tabor, C. Shive, Anna M. Smith, Stephen A. Buia, Anita H. Undale, Karna L. Robinson, Nancy V. Roche, Kimberly M. Valentino, Angela Britton, R. Burges, Debra Bradbury, Kenneth W. Hambright, John Seleski, G. Korzeniewski, Kenyon Erickson, Yvonne Marcus, Jorge Tejada, Mehran Taherian, Chunrong Lu, Margaret J. Basile, Deborah C. Mash, Simona Volpi, Jeffery P. Struewing, Gary F. Temple, Joy T. Boyer, Deborah Colantuoni, Roger Little, S. Koester, Latarsha J. Carithers, Helen M. Moore, P. Guan, Carolyn C. Compton, Sherilyn J. Sawyer, J. Demchok, Jimmie B. Vaught, C. Rabiner, Lockhart +132 moresemanticscholar +1 more sourceMolecular and functional profiling unravels targetable vulnerabilities in colorectal cancer
Molecular Oncology, EarlyView.We used whole exome and RNA‐sequencing to profile divergent genomic and transcriptomic landscapes of microsatellite stable (MSS) and microsatellite instable (MSI) colorectal cancer. Alterations were classified using a computational score for integrative cancer variant annotation and prioritization.Efstathios‐Iason Vlachavas, Konstantinos Voutetakis, Vivian Kosmidou, Spyridon Tsikalakis, Spyridon Roditis, Konstantinos Pateas, Ryangguk Kim, Kymberleigh Pagel, Stephan Wolf, Gregor Warsow, Antonia Dimitrakopoulou‐Strauss, Georgios N. Zografos, Alexander Pintzas, Johannes Betge, Olga Papadodima, Stefan Wiemann +15 morewiley +1 more sourceMultiplex single‐cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer
Molecular Oncology, EarlyView.Cancer stem cells are associated with aggressive disease, but a deep characterization of such markers is lacking in endometrial cancer. This study uses imaging mass cytometry to explore putative cancer stem cell markers in endometrial tumors and corresponding organoid models.Hilde E. Lien, Marta E. Hjelmeland, Hege F. Berg, Rose M. Gold, Kathrine Woie, Lars A. Akslen, Ingfrid S. Haldorsen, Camilla Krakstad +7 morewiley +1 more source
